m6A RNA methylation, a new hallmark in virus-host interactions by Brocard, Michele et al.
m6A RNA methylation, a new hallmark in virus-host interactions 1 
 2 
Brocard Michèle1, Ruggieri Alessia2 and Locker Nicolas1,# 3 
 4 
1Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of 5 
Surrey, Guildford, United Kingdom 6 
2Department of Infectious Diseases, Molecular Virology, University of Heidelberg, 7 
Heidelberg, Germany 8 
 9 
# To whom correspondence should be addressed. Tel: +44-1483689719; Fax: +44; Email: 10 
n.locker@surrey.ac.uk 11 
 12 
Keywords: m6A methylation, epitranscriptome, RNA, RNA virus  13 
 14 
ABSTRACT 15 
 16 
The role of m6A methylation of RNA has remained elusive for decades, however recent 17 
technological advances are now allowing the mapping of the m6A methylation landscape at 18 
nucleotide level. This has spurred an explosion in our understanding of the role played by 19 
RNA epigenetics in RNA biology. m6A modifications have been tied to almost every aspects 20 
of the mRNA life cycle and it is now clear that RNA virus genomes are subject to m6A 21 
methylation. These modifications play various roles in the viral replication cycle. This review 22 
will summarize recent breakthroughs concerning m6A RNA modification and their 23 
implications for cellular and viral RNAs.  24 
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 34 
INTRODUCTION 35 
 36 
The concept of a modified RNA nucleoside emerged 60 years ago with the isolation of a fifth 37 
nucleotide following analysis of soluble RNA from yeast [1]. N6-methyladenosine, or m6A, 38 
was then discovered in the 1970s in a wide range of cellular mRNAs but also in the vaccinia, 39 
Rous sarcoma and influenza viruses’ mRNAs [2-8].  40 
To date more than 100 distinct chemical modifications to RNA have been characterized, most 41 
of which are found to be abundant in non-coding RNA such as tRNA, rRNA and snRNA and 42 
paramount in keeping their functions in translation and splicing [9]. However, recent studies 43 
established that one of the most abundant modifications, m6A, can also be detected internally 44 
in mRNAs, influencing the metabolism and function of mRNAs [9]. Overall, this multitude of 45 
RNA modifications highlights the importance of RNA epigenetics or the epitranscriptome. 46 
m6A RNA modifications are dynamically regulated by methyltransferases or writers, and 47 
demethylases or erasers, and exert their function by either directly being recognized by m6A-48 
binding proteins or readers, or indirectly by tuning the structure of the modified RNA to 49 
regulate RNA-reader protein interactions. Multiple m6A-specific readers have been identified 50 
that affect the metabolism and function of m6A-RNA in various ways, as discussed below 51 
[10-16]. In mammalian cells, the N6-methylation of adenosine is catalysed by a 200 kDa 52 
complex consisting of the methyltransferases Methyltransferase-Like Protein 3 (METTL3), 53 
METTL14 and the associated protein Wilms Tumor 1 Associated Protein (WTAP) [17-22]. 54 
Although it cannot be excluded that uncharacterized writers contribute to m6A methylation, 55 
mouse embryonic stem cell lacking both METTL3 and METTL14 display up to 99% 56 
reduction in m6A signals [23, 24]. Most of these mammalian m6A sites are found within the 57 
consensus RRm6ACH (R=Guanosine or Adenosine, H=Adenosine, Cytidine or Uridine), 58 
which is consistent with the binding motifs identified for METTL14, METTL3 and WTAP 59 
[19]. However, despite this strong consensus only a fraction all possible RRACH sites are 60 
found methylated in vivo which further highlights the dynamic nature of m6A modification. 61 
m6A modification can be removed by two demethylases, Fat mass and Obesity-associated 62 
protein (FTO) and AlkB Homolog 5 (ALKBH5), both of which use different mechanisms to 63 
revert m6A to A [25, 26]. Finally, m6A can also be detected on viral RNA and influences virus 64 
infection and production [27-31].  65 
 66 
UNRAVELLING THE m6A METHYLOME 67 
 68 
The dissection of the m6A landscape has been impaired by the fact that m6A bases cannot be 69 
detected directly by sequencing, as they do not change the base pairing properties and are 70 
indistinguishable from regular bases by reverse transcription. Recently, new methods based 71 
on m6A immunoprecipitation or modification selective RNA chemistry to isolate modified 72 
RNA fragments, coupled with high-throughput sequencing, namely m6A-seq and MeRIP-seq 73 
have identified thousands of hundred-nucleotide fragments containing the modification in the 74 
transcriptomes of mammalian cells [11, 32]. A limitation of these antibody-based methods is 75 
the large amount of RNA material required, precluding experiments at single cell level or with 76 
low abundancy samples. The quality of the antibodies used is also critical with evidence for 77 
artefactual enrichment of mRNA fragments lacking m6A. In addition, m6A antibodies may 78 
have RNA sequence and structure bias [22]. 79 
These approaches were therefore further refined, first by implementing the use of 80 
methyltransferase deficient cells and ligation-based strand specific library preparation [22]. 81 
While in yeast, around only 50% of the m6A peaks are sensitive to depletion of the unique 82 
yeast methyltransferase [22], in human cells the genetic manipulation of methyltransferases 83 
and demethylases resulted in the expected changes in m6A peaks [19, 22, 23, 25] and 84 
thousands of m6A peaks overlap the binding sites for m6A modifying enzymes in vivo [12, 85 
21]. 86 
Finally, single nucleotide resolution m6A mapping can now be achieved by crosslinking the 87 
antibody:RNA complexes through the incorporation of 4-thiouridine and determining the site 88 
of crosslink in enriched RNA fragments [33-35]. These methods have resulted in detection of 89 
over 10,000 m6A sites in the mammalian transcriptome, revealing enrichment in the 3’ 90 
untranslated region (UTR) and near stop codons and satisfyingly, the m6A methylome of 91 
different human cell lines are highly overlapping [11, 23]. 92 
Therefore, high confidence mapping of m6A sites can be achieved using these complementary 93 
approaches. However, most current approaches dissecting the m6A methylome lack 94 
quantitative information. Indeed the impact of RNA modification depends both on function of 95 
individual m6A sites and the fraction of transcripts that have been modified. To address these 96 
stoichiometry issues, a few methods have been developed to quantify the level of m6A 97 
modification at one given loci or on a genome-wide level [36, 37].  98 
 99 
m6A RNA MODIFICATION AND RNA FUNCTION 100 
 101 
Most post-transcriptional steps in gene expression are affected by m6A modification with 102 
mechanistic studies linking it to mRNA stability, splicing, translational efficacy and pri-103 
microRNA processing as summarized in Figure 1 [10, 13-15, 20, 24, 38]. m6A modifications 104 
can exert their functions on mRNA metabolism by affecting interactions with regulatory m6A-105 
binding proteins, or m6A readers, or impacting on RNA structure and acting as structural 106 
switches to alter the accessibility of m6A readers.  107 
m6A RNA modifications impact on RNA structure: 108 
The presence of m6A reduces base pair stability and methylated transcripts are less structured 109 
both in vitro and in vivo than their demethylated counterparts [22, 39-41]. The accumulation 110 
of m6A:U pairs can result in destabilizing AU-rich region and promoting the recruitment of 111 
Heterogeneous Nuclear Ribonucleoprotein C (hnRNPC) by exposing a Uridine-rich sequence, 112 
whose accessibility is otherwise hindered in the unmethylated transcripts [12]. Similarily, 113 
m6A modifications also alter local RNA structure to allow the binding of hnRNPG [42]. By 114 
stimulating the binding of these two reader proteins, m6A modifications therefore regulate 115 
alternative splicing [12, 42]. Furthermore, increased m6A level in response to FTO depletion 116 
results in higher affinity for the splicing factor SRSF2, bolstering the links with RNA splicing 117 
[43].  118 
m6A RNA modifications impact on RNA stability: 119 
Reader proteins from the YTH domain family, YTHDF1-3, can act as m6A readers to regulate 120 
mRNA decay. Depending on the cellular context, YTHDF2 binding to m6A transcripts results 121 
in their re-localisation from the pool of ribosome-associated translatable transcripts to cellular 122 
RNA decay sites such as P-bodies, where the decapping machinery and 5’ to 3’ exonucleases  123 
accumulate. YTHDF2 acts as an adaptor protein in this process as its carboxy-terminal 124 
domain binds to methylated mRNAs while its amino-terminal domain mediates the 125 
localisation to P-bodies [14, 38] (Figure 1). m6A methylation adjacent to binding sites for Hu 126 
antigen R (HuR), an RNA-binding protein that binds AU-rich element to stabilise mRNAs, 127 
reduces HuR binding leading to increased RNA instability [20]. 128 
m6A RNA modifications impact on mRNA translation: 129 
m6A moieties can promote translation when located within 5’ UTRs or near stop codons and 130 
in the 3’ UTR. In the 5’ UTR, m6A-induced ribosome engagement site (MIRES) can bind 131 
directly to the translation factor eIF3 to recruit 43S internally and initiate cap-independent 132 
translation [13] (Figure 1). In contrast, m6A located near stop codons or in the 3’ UTR are 133 
recognised by the reader protein YTHDF1 which then interacts with eIF3 and other ribosome-134 
associated proteins to stimulate cap-dependent ribosome loading [15]. This has also led to the 135 
exciting hypothesis that m6A-driven translation could mediate specific stress-induced 136 
translational responses [13, 38]. Indeed upon heat shock the cytoplasmic reader YTHDF2 can 137 
relocate to nuclear speckles, where it protects the 5’ UTR of stress-induced transcripts from 138 
demethylation by the eraser FTO, resulting in increased translation of these transcripts [38]. 139 
m6A RNA modifications impact on cellular functions: 140 
All these effects suggest the existence of previously unknown RNA regulons involved in 141 
combinatorial control of gene expression [14, 15, 38]. This further impacts on several cellular 142 
functions, with a strong body of evidence connecting m6A modification with mammalian 143 
embryonic stem cell fate and the regulation of pluripotency factors, and also with X 144 
chromosome inactivation, the response to UV-induced DNA damage, metabolic diseases and 145 
the stability of the mammalian circadian clock [20, 24, 25, 44-47].  146 
 147 
m6A RNA MODIFICATION DURING VIRAL INFECTIONS  148 
 149 
While viral RNAs have been known to contain m6A modifications, for example influenza 150 
virus [6], Rous sarcoma virus [8] or simian virus 40 [48], the function of these modifications 151 
and whether the viruses alter the cellular m6A landscape have long remained unanswered 152 
questions. With the development of genome-wide methods to map m6A residues, researchers 153 
are now only beginning to unravel the links between m6A modification and viruses. The 154 
following sections will review five recent studies addressing the role of functional m6A 155 
modifications of transcripts and genomic RNA of human viruses in the context of replicative 156 
infection with human immunodefiency virus type 1 (HIV-1) or Flaviviridae [27-31] (Figure 157 
2).  158 
 159 
m6A RNA MODIFICATION OF HIV-1 gRNA AND mRNA 160 
 161 
By using MeRIP-seq, Lichinchi et al, Kennedy et al and Tirumuru et al all report the 162 
identification of m6A sites on HIV-1 RNA in the cytoplasm of infected cells between 48 and 163 
72hrs post infection, conserved within the three studies [28, 29, 31]. These sites mostly cluster 164 
within three regions of the genome, the 3’ UTR defining the U3/NF-B and TAR clusters, the 165 
nef and U3/nef overlap cluster and the env/rev overlap cluster. In addition, the occurrence of 166 
m6A modifications on some specific loci in individual studies may reflect a dependency of the 167 
m6A landscape to the experimental approach. For instance, Kennedy et al identified two m6A 168 
sites in the HIV-1 primary isolate JR-CSF but not in the laboratory isolate NL4-3 or the 169 
primary isolate BaL [28]. Interestingly one of these coincides with a novel adenosine residue 170 
present only in JR-CSF, and further studies should aim at identifying this unique residue as 171 
the exact site of m6A modification. In addition, Tirumuru et al identified several m6A peaks in 172 
the 5’ UTR leader sequence, the gag gene, the Rev-response element (RRE) and in the rev 173 
gene [31].  174 
Addressing the role of those m6A modifications by suppressing or increasing the activity of 175 
the cellular writers and erasers and measuring the viral replication efficiency, both Tirumuru 176 
et al and Lichinchi et al confirmed the potential for regulatory control of this modification on 177 
viral fitness, ruling out the presence of a viral m6A-modifying enzymatic machinery [29, 31].  178 
Furthermore, Tirumuru et al also showed a functional interaction between the m6A modified 179 
viral RNA and the cellular YTHDF proteins by cross-linking immunoprecipitation (CLIP)-180 
RNAseq and silencing or overexpression assays [31]. 181 
Interestingly, Tirumuru et al demonstrated a remarkable post-entry modulation role for the 182 
m6A modifications located in the U5/TAR and gag region of the HIV-1 NL4-3 genomic RNA 183 
(gRNA) in infected Jurkat and primary CD4+ T cells which is not addressed in the two other 184 
studies. Mechanistic analysis further linked the recognition of this site by the cellular 185 
YTHDF1-3 proteins to a repression of the reverse transcription of the viral gRNA, pointing to 186 
a cellular anti-viral mechanism which could explain differences in infectivity levels between 187 
laboratory strains and cultivable models. This observation may be of particular importance as 188 
m6A modification of viral RNA had been previously described as a cellular innate immune 189 
response escape mechanism, suggesting a wider impact on viral fitness [23]. Furthermore, 190 
m6A modifications have been shown to prevent RNA recognition by the viral sensors TLR3 191 
and TLR7, and an RNA fragment derived from hepatitis C virus (HCV) 5’ UTR was shown to 192 
evade RIG-I sensing in vitro when it contained modified nucleotides, including m6A [49, 50]. 193 
However, further evidence for a role of the m6A methylation pathway in controlling the innate 194 
response against viruses is lacking. Kennedy et al also describe how m6A motifs within the 195 
viral mRNAs 3’ UTRs interacting with YTDH1-3, and in particular YTDH2, contribute to the 196 
stabilisation of the viral mRNAs and are thus linked to strong expression of the viral proteins 197 
in the CD4+ T CEM-SS cell line [28]. 198 
Finally, Lichinchi et al proposed another mechanism involving m6A modification of two 199 
adenosine residues in the stem-loop II region of HIV-1 RRE enhancing the binding of Rev 200 
protein to the HIV-1 RNA, its nuclear export and subsequently increasing viral replication. 201 
Site-directed mutagenesis of those adenosines in the HIV-1 LAI strain showed a dramatic 202 
decrease in viral replication, confirming that the effect seen by the inhibition of the cellular 203 
methyltransferases was mainly due to an effect on the viral RNA rather than on cellular 204 
RNAs. The authors also showed the evolutionary benefit of this mechanism by highlighting 205 
the conservation of those two residues across 2,501 HIV-1 sequences isolated from infected 206 
humans [29].  207 
 208 
m6A RNA MODIFICATION OF FLAVIVIRIDAE GENOMIC RNA 209 
 210 
Perhaps counter-intuitively given the previously described activity of the m6A host machinery 211 
being restricted to the nucleus, similar studies investigating the role of m6A have been 212 
conducted for the single-stranded positive RNA viruses HCV and Zika virus (ZIKV), whose 213 
life cycles remain cytoplasmic [27, 30].  214 
Both studies characterized m6A-modified viral RNAs, leading to the identification of 19 peaks 215 
across the HCV genomic RNA during infection, with the exception of the 3’ UTR, at a global 216 
m6A/A ratio of 0.16%, all adenosine residues included. As for ZIKV, 12 m6A peaks had been 217 
shown, spanning the full length of the genomic RNA packaged into virions, with the 218 
exception of the 5’ UTR, at a striking m6A/A ratio of 3%. Interestingly, further m6A mapping 219 
for different members of the Flaviviridae family highlighted conserved m6A modifications 220 
within the regions coding for the non-structural proteins NS3 and NS5, and within 3’ UTR 221 
sequences, that could suggest conserved functions. 222 
In addition, while the writers METTL3 and 14 activity is associated with a restriction of viral 223 
replication, the erasers FTO and ALKBH5 exert an opposite effect in infected cell culture, 224 
suggesting that a negative regulation of viral replication by m6A modification. Further 225 
mechanistic studies identified that (i) the YTHDF proteins mediate this m6A-associated 226 
regulation of the viral life cycle and (ii) this effect is due to modification of the viral genomic 227 
RNAs rather than to changes in the m6A cellular methylome as discussed in more detail 228 
below. 229 
Unlike the effect described on cellular mRNAs, Gokhale et al propose that m6A modification 230 
does not seem to have any effect on the stability or on the translation efficiency of HCV RNA 231 
[27]. However, the authors identified a direct interaction between the m6A modified HCV 232 
RNA and YTHDF proteins, and showed an inverse correlation with its packaging into newly 233 
produced virions in the cytoplasm of infected cells (Figure 2). The comparison between the 234 
methylome of the HCV RNA and YTHDF binding sites identified by PAR-CLIP analysis, 235 
revealed a unique region consisting of m6A sites clustered within the envelope E1 coding 236 
region, both containing m6A modifications and bound by YTHDF proteins, as responsible for 237 
this molecular switch from one step of the viral life cycle to the other. This E1 coding region 238 
cluster displays a greater affinity for all YTDH when methylated, which in turn prevents the 239 
binding of HCV Core protein to the viral RNA and results in impaired virion packaging. 240 
Corroborating these results, the authors also showed a very low occurrence of m6A 241 
modifications in virions from the supernatant of infected cells compared to cytoplasmic viral 242 
RNA. Furthermore, confocal microscopy analysis suggested that YTHDF1-3 relocates to the 243 
lipids droplets associated with sites of virion assembly in infected cells, compared to their 244 
more diffuse cellular distribution in uninfected cells, suggesting an active recruitment to the 245 
viral replication sites in infected cells. The conservation of several m6A sites within this 246 
region between different HCV strains further supports the role that m6A modification could 247 
play in controlling the fate of the viral RNA and packaging into virions.  248 
However, the MeRIP-seq analysis of different viruses belonging to the Flaviviridae family, 249 
dengue virus, yellow fever virus, West Nile virus, and ZIKV strains DAK and PR2015 did not 250 
reveal any conservation of the E1 coding region region m6A modification. Yet, all the 251 
flavivirus RNAs contain m6A sites within the NS5 coding regions and the 3’ UTRs. The 252 
functional significance of this observation remains to be dissected as the analysis was carried 253 
out in infected human hepatoma-derived Huh7 cells at different time-point (24hrs to 48hrs), 254 
without evidence of conducting the analysis at the relevant time point for each virus [27]. 255 
Furthermore, the use of poly(A)+ RNA selection for the MeRIP experiment whilst the viral 256 
RNAs studied do not contain poly(A) tails may have resulted in some bias.  257 
In contrast with these results, Lichinchi et al identified 12 sites of m6A modifications in the 258 
ZIKV strain MR766 RNA in HEK 293T cells and suggested that these modifications result in 259 
the destabilisation of the viral RNA and impact on viral replication. The binding of YTHDF2 260 
to m6A sites in the ZIKV 3’ UTR results in the relocalisation of the m6A modified viral RNA 261 
with the cellular mRNA decay machinery. Furthermore, the absence of m6A modification in 262 
YTHDF2 knock-out cells results in increased viral protein expression and viral replication 263 
[27, 30]. 264 
Interestingly, as shown for HIV-1, the locations of m6A modifications identified for ZIKV 265 
RNA in the two studies do not perfectly overlap, potentially reflecting the use of different 266 
viral strains and cellular models. Bolstering this observation, Gokhale et al showed important 267 
differences between the two ZIKV strains investigated despite the use of the same cell line 268 
[27]. The existence of such variability in the topology of the m6A modifications of viral RNA 269 
strongly could reflect its importance as a dynamic, given its potential to be reverted, versatile 270 
tool of adaption to the host. However, this strain-related variability of m6A topology also 271 
demonstrates how much those studies have to be primly initially comparative rather than 272 
mechanistic, and perhaps most of the divergent m6A modifications are unlikely to be of 273 
biological relevance in these simple ex vivo in vitro models. Ideally, this analysis of the viral 274 
RNA m6A landscape may rather be carried out on material isolated from clinical samples 275 
rather than viral RNA synthesised by replication in permissive cell lines. The quintessential 276 
principle of epigenetics markings, as a tool of finely tuned adaptation to a defined 277 
environment -or host when in view of viruses-, thus resides both in its vertical conservation 278 
and its versatility. 279 
 280 
CHANGES IN CELLULAR m6A LANDSCAPE UPON INFECTION 281 
 282 
The main outcomes of the studies discussed above is the dissection of how m6A modification 283 
of viral RNAs regulate HIV-1 and Flaviviridae replication in cell cultures, however, 284 
Lichinchi et al a and b, and Tirumuru et al also provide a comprehensive analysis of the 285 
changes in the m6A cellular epitranscriptome. In particular, the identification of modified 286 
transcripts involved in immune and viral infection evasion pathways may have important 287 
consequences in vivo [27-31].  288 
While HIV-1 infection in Jurkat cells and primary CD4+ T cells does not result in significant 289 
differences in the abundance of total m6A peaks mapped to the human transcriptome 290 
compared to uninfected cells, the analysis of the preferred motifs showed a slight increase of 291 
the frequency of the consensus RRACH motif and a corresponding decrease of the GGACU 292 
motif frequency [31]. Further gene ontology analysis of the m6A-modified cellular genes 293 
associate this redistribution of m6A sites with functional clustering in pathways involved in 294 
viral infection and in wider processes such as metabolism, the immune system, multicellular 295 
organismal processes and development. In contrast, using a different analytical approach, 296 
Lichinchi et al identified 56 cellular gene transcripts specifically methylated upon HIV-1 297 
infection of another T cell line, MT4 cells [29]. Interestingly, 19 of these have previously 298 
been associated with HIV replication and promote viral replication or directly interact with 299 
viral proteins [29].  300 
In addition, changes in the distribution of m6A peaks across the 5’ UTR, CDS, 3’ UTR and 301 
intronic sequences for these HIV-1 specific cellular methylated transcripts, when compared 302 
with total cellular mRNA, are reported as 17.5%, 66%, 14.4% and 2.1% compared to 13.4%, 303 
41%, 31.6% and 14%, respectively. This suggests that these m6A modifications may exert 304 
functions in RNA splicing and translation rather than in RNA stabilisation. Furthermore, 305 
HIV-1 infection results in the enrichment of MGACK m6A motifs in cellular motifs (where 306 
M=Adenosine or Cytidine and K=Guanosine or Uridine), mimicking the changes observed for 307 
the viral RNA.  308 
ZIKV infection also results in changes in the distribution of m6A modification with an 309 
increase within the 5’ UTR of the host transcripts and a corresponding decrease within the 3’ 310 
UTR regions suggesting an effect on cellular mRNA splicing, stabilisation and translation 311 
[30]. Analysis of the consensus sequence further showed a switch in motif usage from 312 
RAACH over RGACH upon ZIKV infection. Gene ontology analysis revealed that both the 313 
gained and lost m6A modifications are linked to immune–related pathways, which may lead to 314 
the suppression of immune surveillance systems or disturb other cellular processes to ensure 315 
viral replication [30].  316 
 317 
CONCLUSIONS AND PRACTICAL CONSIDERATIONS 318 
 319 
Taken together, these studies demonstrate that m6A RNA modification of viral RNA is likely 320 
to illustrate a broad range of adaptive host-pathogen interactions throughout all steps of the 321 
viral life cycle. The first 3 studies describe 3 different mechanisms involved in HIV-1 viral 322 
fitness that are described as modulated by m6A modification of the viral mRNA and genomic 323 
RNA, respectively [29], [28] and [31]. This illustrates how promising the study of this 324 
mechanism could be in terms of both broadening and elaborating our understanding of host-325 
pathogen interactions during viral infection. But beyond the renewed excitement for RNA 326 
epigenetics in microbiology, the converse effects of the m6A modifications of the HIV-1 327 
RNAs at different steps of the viral life cycle point out the need for more systemic and 328 
dynamic approaches in physiologically relevant cellular context if we were to gain a 329 
comprehensive and translatable knowledge of the functionality of this epitranscriptomics 330 
event. Two additional studies focussing on Flaviviridae are remarkably providing examples 331 
of absolute cytoplasmic m6A modifications of the viral genomic RNAs [27] and [30]. While 332 
reporting novel and unique mechanisms of regulation of the viral replication of HCV and 333 
ZIKV, those publications also highlight the obvious need for a standardised dynamic 334 
approach to the investigation of viral RNA m6A modification during infection. This should 335 
also prompt further studies to dissect the functional relationships between different viral 336 
systems and the m6A epitranscriptome. This is relevant as well for viruses such as influenza 337 
virus or SV40 that were found to contain m6A modification in the first studies discovering 338 
m6A residues.  339 
The recent advances in RNA sequencing and commercialisation of the m6A antibody have 340 
made the study of the modifications of the m6A landscape of viral and cellular genomes at the 341 
nucleotide level a readily available and straightforward process. The non-exhaustive list 342 
suggested in table 1 recapitulates the practical approaches that could be used for the standard 343 
investigation of this event, also relevant in many types of biological processes. For technical 344 
reasons and perhaps financial impediments, complete investigations cannot be carried out in a 345 
systematic manner in different cellular models or using a variety of viral strains. However, the 346 
functional mechanisms discovered should be validated and addressed from a dynamic point of 347 
view, bearing in mind that comparison with non-replicative models may also broaden our 348 
general understanding. Finally, key technological improvements in the near future should 349 
enable a move from mapping the epitranscriptome to understanding the biological function of 350 
individual modifications. The implementation of CRISPR-based genome editing will enable 351 
to specifically alter single m6A sites to interrogate the biological function of specific 352 
modifications, helping to unravel new functions for m6A modification in viral replication. 353 
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FIGURE LEGENDS 522 
 523 
Figure 1. Regulation of m6A RNA modifications. Methylation (CH3) of adenosine (A) on 524 
position N6 to form N6-methylated A (m6A) is catalysed by writers such as the 525 
methyltransferase complex composed of METTL3, METTL14 and WTAP. This process is 526 
reversible and methylation is removed by demethylases or erasers such as FTO and ALKBH5. 527 
m6A RNA modifications are recognized and bound by readers such as among others proteins 528 
of the YTHDF family, but also SRSF2, hnRNPC, and hnRNPG (i.e other readers). Depending 529 
on the cellular context and their position in mRNAs, m6A RNA modifications can (i) result in 530 
the recruitment of splicing factors favouring alternative splicing, (ii) promote mRNA 531 
destabilisation and degradation in P-bodies by the decay machinery, and (iii) promote 532 
translation. 533 
 534 
Figure 2. m6A RNA modifications affect viral cycles by different mechanisms. HIV-1 535 
genomic RNA is methylated (m6A) in a post-entry step. Recognition and binding of these 536 
m6A sites by the readers YTHDF1-3 represses reverse-transcription of the genomic RNA into 537 
the proviral dsDNA. In the nucleus, m6A modification in the Rev-responsive element (RRE) 538 
region of HIV-1 genomic RNA favours Rev binding, its nuclear export, gag protein synthesis 539 
and viral replication (lower panel). Although Flaviviridae life cycle remains cytosolic, HCV 540 
RNA genome can be methylated at several positions. Interestingly, methylation sites 541 
clustering in the E1 ORF region are recognized by YTHDF proteins which localize to lipid 542 
droplets upon infection, thereby prevent binding of the genome with Core proteins and its 543 
packaging into viral particles (upper panel). 544 
 545 
TABLES 546 
 547 
Table 1: Suggested workflow for studying the role of m6A epitranscriptomics during 
viral infection. 
Rapid assessment of 
m6A involvement 
during viral infection. 
Poly(A)+ and total RNA Dot-Blots of cellular and viral RNA 
using m6A antibodies.  
Dynamic synopsis of 
the m6A 
epitranscriptome. 
m6A RNA immunoprecipitation (RIP) and qPCR on RNA 
contained in virions, post entry, at replication, translation and 
egress (or latent against lytic) steps.  
Genome-wide 
mapping of m6A 
modified transcripts. 
(i) MeRIP-Seq experiments to map m6A sites on cellular and 
viral RNAs. 
(ii) Metagene analysis of normalized m6A peaks to determine the 
gene ontology distribution, topology and motif preferences of the 
m6A modification and its evolution upon viral infection. 
(iii) In silico sequence analysis of different viral strains to assess 
the level of conservation of identified motifs, indicating a degree 
of causality with roles in viral fitness. 
Assigning biological 
functions to specific 
m6A sites. 
(i) RIP-Seq analysis for viral or cellular readers to generate 
correlation maps between unique m6A modifications and sites of 
interactions with m6A readers. 
(ii) Site-directed mutagenesis of viral m6A sites identified by 
MeRIP-Seq and refined by readers RIP-Seq. Care should be 
taken to ensure particular mutations do not affect the function of 
the encoded viral proteins or RNA structures (this may require a 
thorough in vitro and in vivo analysis or the use of reporter 
models). 
Assessing regulatory 
roles for m6A 
modifications. 
(i) Viral replication assays in cells silenced for components of 
the m6A editing machinery or overexpressing these components.  
(ii) Subcellular localization analysis of viral proteins, replication 
complexes and identified m6A readers to illustrate the spatio-
 temporal dynamic of these interactions, contributing to an 
integrated understanding of this new layer of virus-host 
interactions. 
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